Guided by these results, we developed a highly multiplexed parallel reaction monitoring (PRM) assay for precise quantitation of 90 proteins that are associated with cancer metabolism, RNA regulation, and major cancer growth–associated pathways, such as PI3K/AKT/mTOR and EGFR/RAS/RAF. The gene discussed is AKT1; the disease is cancer.